ACELYRIN, INC Common Stock
Price & Volume
Stats
See more52W Range | $3.10-$8.88 |
Market Cap | $316M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.46 |
News
See moreYahoo Finance • last year
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline
Yahoo Finance • last year
ACELYRIN, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; January 16, 2023 deadline
Yahoo Finance • last year
Lowey Dannenberg Notifies ACELYRIN, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
Yahoo Finance • last year
Kaplan Fox & Kilsheimer LLP Investigates Acelyrin, Inc. (Nasdaq: SLRN)
About
CEO | Ms. Mina Kim J.D. |
CFO | Mr. Gilbert M. Labrucherie J.D. |
Address | 4149 Liberty Canyon Road, Agoura Hills, CA, United States, 91301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 135 |
